Trial Hold And Downgrades Sink Alcobra By 50%


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Alcobra Ltd (NASDAQ: ADHD) shares are trading higher lower by $2.57 at $2.05, or 55 percent lower in Thursday's session.

After announcing an IND clinical hold affecting the MDX Phase III Measure Study, both Oppenheimer and Cantor Fitzgerald downgraded the issue.

The issue, which debuted in October 2013 at the $8 level, when on to make its all-time high in March 2014 at $24.79 before embarking on a long-term downtrend.

The study being put on hold has investors heading to the exit in the issue. Following a sharply lower open ($2.19 vs. Wednesday's close of $4.62), it managed a slight bounce to $2.35 before resuming its moves lower.

It has gone on to make a new all-time low at $1.95 and found a host of buyers that brought it back into the $2 handle.

Today's price action is taking place on much higher than average volume. With four hours remaining in the session, nearly 6 million shares compared to its 20-day average of only 282,000.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: TechnicalsIntraday UpdateMoversTrading Ideas